PLN-/PALN- median (range) | PLN + /PALN- median (range) | PALN + median (range) | p-value | |
---|---|---|---|---|
Tumor metabolic activity | n = 71 | n = 45 | n = 32 | |
SUVmax | 13.9 (2.1–46.3) | 15.7 (7.3–34.4) | 14.8 (6.0–23.9) | 0.008 |
MTV (cc) | 25.9 (0.8–162.0) | 48.6 (8.8–127.0) | 52.3 (10.5–299.0) | 0.001 |
TLG (g/mL*cm3) | 197.6 (1.2–2495.0) | 432.7 (43.4–2204.0) | 353.4 (42.2–3181.0) | 0.001 |
PLN metabolic activity | n = 45 | n = 27 | ||
SUVmax | N/A | 6.7 (1.7–23.9) | 6.6 (1.8–16.1) | 0.794 |
SUVmean | N/A | 4.0 (1.3–12.6) | 4.1 (1.6–9.0) | 0.907 |
Ratio of PLN SUVmax/tumor SUVmax | N/A | 0.40 (0.10–1.25) | 0.49 (0.12–0.95) | 0.467 |
MTVPLN (cc) | N/A | 1.9 (0.3–22.8) | 2.4 (0.2–8.8) | 0.646 |
TLG (g/mLxcm3) | N/A | 6.8 (0.6–152.2) | 10.4 (0.4–76.8) | 0.831 |